Exelixis | Bénéfice Avant Impôts

Pre Tax Profit Changement Date
Acadia Pharmaceuticals USD 39.7M 91.85M 2023-12
Agios Pharmaceuticals USD -95940000 4.62M 2023-12
Akebia Therapeutics USD 614K 15.1M 2023-12
Amgen USD 3.03B 153M 2023-12
Bayer EUR 1.17B 975M 2022-09
BioMarin Pharmaceutical USD 33.33M 8.34M 2023-12
Bluebird Bio USD -71731000 1.26M 2023-09
Bristol-Myers Squibb USD 4.07B 613M 2023-12
Cytokinetics USD -136896000 7.47M 2023-12
Eisai JPY 7.37B 20.91B 2023-09
Eli Lilly USD 2.59B 2.27B 2023-12
Esperion Therapeutics USD -41250000 8.68M 2023-09
Exelixis USD 103.04M 97.22M 2023-12
Genmab DKK 2.7B 979M 2023-09
Incyte USD 319.15M 14.94M 2023-09
Ionis Pharmaceuticals USD -3000000 138M 2023-12
Merck USD -473000000 6.86B 2023-12
Moderna USD 70M 2.03B 2023-12
Nektar Therapeutics USD -45898000 5.27M 2023-09
Neurocrine Biosciences USD 198.2M 82.6M 2023-12
Pfizer USD -1250000000 5.38B 2023-09
Takeda JPY -95980000000 231.01B 2023-09
Ultragenyx Pharmaceutical USD -126892000 32.11M 2023-12
Xencor USD -13452000 10.82M 2023-12



Exelixis Bénéfice Avant Impôts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2024.